WallStreetZenWallStreetZen

NASDAQ: DAWN
Day One Biopharmaceuticals Inc Stock Ownership - Who owns Day One Biopharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Day One Biopharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lauren MerendinoChief Commercial Officer2025-08-183,766$6.77
$25.48kSell
Jeremy BenderCHIEF EXECUTIVE OFFICER2025-08-1816,058$6.77
$108.66kSell
Charles N. York IiCOO and CFO2025-08-184,106$6.77
$27.79kSell
Adam DubowGen Counsel Secretary2025-08-184,365$6.77
$29.54kSell
Lauren MerendinoChief Commercial Officer2025-05-163,927$6.26
$24.58kSell
Adam DubowGENERAL COUNSEL2025-05-164,552$6.26
$28.49kSell
Jeremy BenderCHIEF EXECUTIVE OFFICER2025-05-1613,964$6.26
$87.39kSell
Charles N. York IiCOO CFO AND SECRETARY2025-05-164,282$6.26
$26.80kSell
Adam DubowGENERAL COUNSEL2025-02-184,646$11.96
$55.58kSell
Charles N. York IiCOO CFO AND SECRETARY2025-02-184,370$11.96
$52.28kSell

1 of 2

DAWN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DAWN insiders and whales buy or sell their stock.

DAWN Shareholders

What type of owners hold Day One Biopharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ai Day1 LLC12.62%12,929,322$96.84MInsider
Fmr LLC11.07%11,342,699$84.96MInstitution
Papanek Julie Grant10.93%11,199,207$83.88MInsider
Blackrock Inc9.60%9,830,431$73.63MInstitution
Ai Day 1 LLC9.16%9,377,776$70.24MInsider
Canaan XI LP6.80%6,964,301$52.16MInsider
Atlas Venture Life Science Advisors LLC6.28%6,430,257$48.16MInstitution
Atlas Venture Fund XI LP6.11%6,258,534$46.88MInsider
Vanguard Group Inc6.03%6,176,495$46.26MInstitution
Takeda Pharmaceutical Co Ltd5.97%6,120,124$45.84MInsider

1 of 3

DAWN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DAWN56.90%43.10%Net SellingNet Selling
GYRE2.05%97.95%Net Buying
NKTR23.75%76.25%Net SellingNet Selling
GLUE34.03%65.97%Net Selling
PVLA48.78%51.22%Net Buying
View Top Biotech Stocks

Day One Biopharmaceuticals Stock Ownership FAQ

Who owns Day One Biopharmaceuticals?

Day One Biopharmaceuticals (NASDAQ: DAWN) is owned by 84.14% institutional shareholders, 63.73% Day One Biopharmaceuticals insiders, and 0.00% retail investors. Ai Day1 LLC is the largest individual Day One Biopharmaceuticals shareholder, owning 12.93M shares representing 12.62% of the company. Ai Day1 LLC's Day One Biopharmaceuticals shares are currently valued at $96.97M.

If you're new to stock investing, here's how to buy Day One Biopharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.